SCHEMBL31665584

SCHEMBL31665584

Cc1ccc(NC(=O)c2ccccc2C)cn1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.63
SMN1; SMN2 Q16637 3/20 0.62
L3MBTL1 Q9Y468 1/20 0.61
NPC1 O15118 4/20 0.60
RAB9A P51151 4/20 0.60
TYK2 P29597 1/20 0.60
CYP1A2 P05177 1/20 0.60
PIK3CA P42336 1/20 0.56
MTOR P42345 1/20 0.56
SORT1 Q99523 1/20 0.56
FFAR1 O14842 1/20 0.55
BLK P51451 1/20 0.54
HTT P42858 2/20 0.54
ALOX15 P16050 1/20 0.54
TP53 P04637 1/20 0.54
MAPK1 P28482 1/20 0.54
MAPT P10636 1/20 0.54
THRB P10828 1/20 0.54
LMNA P02545 1/20 0.54
GAA P10253 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25143492 1.00 HPGD (0.63) HPGDSMN1; SMN2L3MBTL1NPC1RAB9A
SCHEMBL12173061 0.86 SORT1 (0.69) L3MBTL1CYP1A2PIK3CAMTORSORT1
SCHEMBL31110254 0.85 PIK3CA (0.60) SMN1; SMN2NPC1RAB9APIK3CAMTOR
SCHEMBL25143324 0.85 PIK3CA (0.60) SMN1; SMN2NPC1RAB9APIK3CAMTOR
SCHEMBL22340592 0.84 KMT2A (0.63) SMN1; SMN2NPC1RAB9ATP53MAPK1
SCHEMBL25143434 0.82 MEN1 (0.55) SMN1; SMN2NPC1RAB9APIK3CAMTOR
SCHEMBL31665572 0.82 MEN1 (0.55) SMN1; SMN2NPC1RAB9APIK3CAMTOR
SCHEMBL22323774 0.81 MEN1 (0.67) SMN1; SMN2NPC1RAB9AALOX15TP53
SCHEMBL13162689 0.81 ALDH1A1 (0.70) HPGDTYK2HTTMAPK1ALDH1A1
SCHEMBL31110262 0.81 KCNQ3 (0.67) SMN1; SMN2NPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250235543-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2025-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250235543-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, TP53BP1 HPGD 3546/4885SMN1; SMN2 2871/4885L3MBTL1 1176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.